Bionomics Announces Plans to Conduct U.S. Initial Public Offering
Ryan Allway August 2nd, 2021 Psychedelics ADELAIDE, Australia, Aug. 2, 2021 /PRNewswire/ — Bionomics Limited (ASX: BNO,OTCQB: BNOEF), (Bionomics) a global, clinical stage biopharmaceutical company, is pleased to announce that it plans to conduct a registered initial public offering of American Depositary Shares (ADSs) in the United States and a... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )